ICD-10 Coding for Classical Hodgkin Lymphoma(C81.0, C81.0P, C81.1)
Explore detailed ICD-10 coding guidelines for classical Hodgkin lymphoma, including subtype specifications and documentation requirements.
Complete code families applicable to Classical Hodgkin Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C81.1 | Nodular sclerosis classical Hodgkin lymphoma | Use when biopsy confirms nodular sclerosis subtype with specific immunophenotyping results. |
|
| C81.2 | Mixed cellularity classical Hodgkin lymphoma | Use when biopsy confirms mixed cellularity subtype. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutClassical Hodgkin Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Classical Hodgkin Lymphoma.
Failure to document B symptoms when present.
Impact
Clinical: May affect treatment decisions and prognosis., Regulatory: Could lead to audit issues., Financial: Potential loss of reimbursement for additional complexity.
Mitigation
Ensure thorough documentation of symptoms., Regularly review patient records for symptom updates.
Using unspecified codes when subtype is documented.
Impact
Reimbursement: May lead to reduced reimbursement due to lack of specificity., Compliance: Increases risk of audit due to unspecified coding., Data Quality: Decreases data accuracy and quality.
Mitigation
Ensure documentation specifies the subtype for accurate coding.
Unspecified coding
Impact
Using unspecified codes when subtype is available.
Mitigation
Educate providers on importance of specifying subtypes in documentation.